New treatment for relapsed or refractory Hodgkin's lymphoma

被引：4
|
作者：
Gourd, Elizabeth
机构：
来源：
LANCET ONCOLOGY | 2019年 / 20卷 / 06期
关键词：
D O I：
10.1016/S1470-2045(19)30289-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E298 / E298
页数：1
相关论文
共 50 条
  • [21] Therapy of relapsed and refractory Hodgkin Lymphoma
    von Tresckow, B.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 62 - 62
  • [22] Managing relapsed and refractory Hodgkin lymphoma
    Brice, Pauline
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (01) : 3 - 13
  • [23] Pembrolizumab for relapsed or refractory Hodgkin lymphoma
    Pulsoni, Alessandro
    LANCET ONCOLOGY, 2020, 22 (06): : E234 - E234
  • [24] Gemcitabine combined with oxaliplatin in the treatment of relapsed or refractory Hodgkin lymphoma
    Coliat, P.
    El Aatmani, A.
    Berceanu, A.
    Leveque, D.
    Herbrecht, R.
    Beretz, L.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (02) : 459 - 459
  • [25] Gemcitabine as single agent in the treatment of relapsed and refractory Hodgkin's and non-Hodgkin lymphoma.
    Jajeh, A
    Hadad, L
    Zalzaleh, G
    Ruestow, P
    BLOOD, 2003, 102 (11) : 285B - 285B
  • [26] Relapsed/Refractory Classical Hodgkin Lymphoma
    Winter, Jane N.
    TURKISH JOURNAL OF HEMATOLOGY, 2023, 40 : 34 - 35
  • [27] Brentuximab vedotin treatment in patients with relapsed or refractory Hodgkin lymphoma
    Zsuzsa, Molnar
    Imre, Pinczes Laszlo
    Klara, Piukovics
    Ildiko, Istenes
    Krisztina, Wolf
    Zoltan, Csukly
    Arpad, Szomor
    Arpad, Illes
    Zsofia, Miltenyi
    ORVOSI HETILAP, 2017, 158 (41) : 1630 - 1634
  • [28] Treating Hodgkin lymphoma in the new millennium: Relapsed and refractory disease
    LaCasce, Ann S.
    HEMATOLOGICAL ONCOLOGY, 2019, 37 : 87 - 91
  • [29] Single Institution Experience with Nivolumab in Treatment of Patients with Relapsed or Refractory Hodgkin's Lymphoma
    Kasperova, Barbora
    Ladicka, Miriam
    Drgona, Lubos
    Greksak, Radoslav
    Bizikova, Ivona
    Fekete, Ladislav
    Razus, Martin
    Vranovsky, Andrej
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S323 - S324
  • [30] High dose sequential chemotherapy: An effective treatment in relapsed and refractory Hodgkin's lymphoma
    Nassi, L.
    Rigacci, R.
    Guidi, S.
    Lombardini, L.
    Nozzoli, C.
    Gozzini, A.
    Mappa, S.
    Puccini, B.
    Carrai, V
    Alterini, R.
    Bernardi, F.
    Saccardi, R.
    Bosi, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 187 - 187
12345